EU MDR's New Timetable: Are You Ready for 2025, 2027, and 2028?

This episode delves into the crucial extended transition deadlines for the EU Medical Device Regulation (EU MDR), now set for 2027 and 2028. We explore what these extensions mean for manufacturers of legacy medical devices, emphasizing the critical actions that should have been completed by May and September 2024 to benefit from this extra time. The focus for 2025 shifts from new extension-specific filings to the continuous maintenance of an MDR-compliant Quality Management System, robust post-market surveillance, and up-to-date technical documentation, ensuring devices remain safe and that manufacturers are audit-ready. Key Questions: • What are the new EU MDR compliance deadlines for 2027 and 2028? • Did your company meet the critical May 26, 2024, application deadline? • Was a signed agreement with a Notified Body in place by September 26, 2024? • What does "maintaining compliance" truly mean for legacy devices in 2025? • Are there new EU MDR filings required in 2025 for the extension? • How does post-market surveillance change for legacy devices under these extensions? • What happens if significant changes are made to a legacy device? • What are the consequences of not meeting the 2024 prerequisites? • How can manufacturers ensure their QMS remains MDR-compliant throughout 2025? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email [email protected] for tailored support.